To include your compound in the COVID-19 Resource Center, submit it here.

Sarilumab: Phase IIb data

Data from Part A of the double-blind, dose-ranging, international Phase IIb MOBILITY trial in 306 patients with active RA who had an inadequate response to

Read the full 252 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE